2018. ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN’’S LYMPHOMA. Voprosy onkologii. 64, 3 (Mar. 2018), 414–418. DOI:https://doi.org/10.37469/0507-3758-2018-64-3-414-418.